Details

Autor(en) / Beteiligte

• Mehta, Yatin
• Jaggi, Namita
• Rosenthal, Victor Daniel
• Kavathekar, Maithili
• Sakle, Asmita
• Munshi, Nita
• Chakravarthy, Murali
• Todi, Subhash Kumar
• Saini, Narinder
• Rodrigues, Camilla
• Varma, Karthikeya
• Dubey, Rekha
• Kazi, Mohammad Mukhit
• Udwadia, F. E.
• Myatra, Sheila Nainan
• Shah, Sweta
• Dwivedy, Arpita
• Karlekar, Anil
• Singh, Sanjeev
• Sen, Nagamani
• Limaye-Joshi, Kashmira
• Ramachandran, Bala
• Sahu, Suneeta
• Pandya, Nirav
• Mathur, Purva
• Sahu, Samir
• Singh, Suman P.
• Bilolikar, Anil Kumar
• Kumar, Siva
• Mehta, Preeti
• Padbidri, Vikram
• Gita, N.
• Patnaik, Saroj K.
• Francis, Thara
• Warrier, Anup R.
• Muralidharan, S.
• Nair, Pravin Kumar
• Subhedar, Vaibhavi R.
• Gopinath, Ramachadran
• Azim, Afzal
• Sood, Sanjeev

Titel

Device-Associated Infection Rates in 20 Cities of India, Data Summary for 2004–2013: Findings of the International Nosocomial Infection Control Consortium

Ist Teil von

• Infection control and hospital epidemiology, 2016-02, Vol.37 (2), p.172-181

Ort / Verlag

New York, USA: Cambridge University Press

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• To report the International Nosocomial Infection Control Consortium surveillance data from 40 hospitals (20 cities) in India 2004-2013. Surveillance using US National Healthcare Safety Network's criteria and definitions, and International Nosocomial Infection Control Consortium methodology. We collected data from 236,700 ICU patients for 970,713 bed-days Pooled device-associated healthcare-associated infection rates for adult and pediatric ICUs were 5.1 central line-associated bloodstream infections (CLABSIs)/1,000 central line-days, 9.4 cases of ventilator-associated pneumonia (VAPs)/1,000 mechanical ventilator-days, and 2.1 catheter-associated urinary tract infections/1,000 urinary catheter-days In neonatal ICUs (NICUs) pooled rates were 36.2 CLABSIs/1,000 central line-days and 1.9 VAPs/1,000 mechanical ventilator-days Extra length of stay in adult and pediatric ICUs was 9.5 for CLABSI, 9.1 for VAP, and 10.0 for catheter-associated urinary tract infections. Extra length of stay in NICUs was 14.7 for CLABSI and 38.7 for VAP Crude extra mortality was 16.3% for CLABSI, 22.7% for VAP, and 6.6% for catheter-associated urinary tract infections in adult and pediatric ICUs, and 1.2% for CLABSI and 8.3% for VAP in NICUs Pooled device use ratios were 0.21 for mechanical ventilator, 0.39 for central line, and 0.53 for urinary catheter in adult and pediatric ICUs; and 0.07 for mechanical ventilator and 0.06 for central line in NICUs. Despite a lower device use ratio in our ICUs, our device-associated healthcare-associated infection rates are higher than National Healthcare Safety Network, but lower than International Nosocomial Infection Control Consortium Report.